Press release
Analysis of Key Market Segments Driving the Gestational Diabetes Market
Gestational Diabetes Market
Forecasted Market Size and Growth Prospects of the Gestational Diabetes Market
The gestational diabetes market is projected to reach a value of $13.85 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.7%. This anticipated growth is fueled by the increasing prevalence of gestational diabetes, advancements in digital health monitoring technologies, better prenatal diagnostic tools, a stronger emphasis on preventive maternal care, and supportive healthcare policies. Key trends shaping this market include broader adoption of blood glucose monitoring devices, greater use of insulin therapy during pregnancy, heightened focus on managing the condition through lifestyle changes, expansion of prenatal screening initiatives, and rising awareness about maternal health.
Download a free report of the gestational diabetes market report:
https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Driving Innovation and Growth in the Gestational Diabetes Sector
The gestational diabetes market includes several leading players such as Sanofi S.A., Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton dic*kinson and Company, Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc, Novartis AG, Adocia SA, and Daiichi Sankyo Company Ltd.
In a notable development in April 2024, UK-based diabetes home-testing company Digostics teamed up with AgaMatrix Europe to enhance gestational diabetes screening. This collaboration enables AgaMatrix to exclusively distribute Digostics' home oral glucose tolerance testing service, GTT@home, within the UK National Health Service (NHS). Leveraging AgaMatrix's established NHS maternity service relationships and expertise in gestational diabetes monitoring, this partnership aims to accelerate the adoption of convenient, home-based screening solutions across the UK market.
View the full gestational diabetes market report:
https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Key Factors Encouraging Expansion in the Gestational Diabetes Market
Innovations in medical technology are playing a pivotal role in the gestational diabetes space. For example, companies are focusing on developing products that improve patient outcomes through precision and customization. Advanced 3D-printed patient-specific implants illustrate this trend by offering tailored medical solutions based on individual anatomy, which can reduce surgery times and enhance recovery.
A case in point occurred in April 2024 when 3D Systems, a US-based medical device and 3D printing firm, received FDA clearance for its VSP PEEK Cranial Implant. This implant, created using medical-grade polyether ether ket*one (PEEK) and additive manufacturing, supports cranial reconstruction with high precision. The technology employs computer-aided design and 3D printing to produce implants that fit closely to patient-specific anatomy, helping surgeons achieve better clinical outcomes.
Segmentation Overview of the Gestational Diabetes Market
The gestational diabetes market is structured into several key segments to provide a detailed view of the industry:
1) By Type:
- Type A1
- Type A2
- Other Types
2) By Treatment:
- Monitoring
- Drug Treatment
- Non-pharmacological Treatment
3) By Administration:
- Oral
- Intravenous
- Other Administration Methods
4) By End User:
- Hospitals
- Clinics
- Home Care Settings
- Diagnostic Centers
Further subcategories break down the types more specifically:
- Type A1 includes diet-controlled and exercise-controlled gestational diabetes.
- Type A2 covers insulin-controlled and oral medication-controlled gestational diabetes.
- Other Types encompass pre-gestational diabetes and gestational diabetes with complications.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Analysis of Key Market Segments Driving the Gestational Diabetes Market here
News-ID: 4479305 • Views: …
More Releases from The Business Research Company
Trypsin-EDTA Solution For Cell Dissociation Market Research Reveals Path To $2.0 …
The trypsin-EDTA solution for cell dissociation market is poised for remarkable expansion as advances in cell therapy and biomanufacturing continue to accelerate. With increasing demands for efficient and reliable cell processing methods, this sector is on track to experience dynamic growth over the next several years. The following overview explores the market's anticipated size, leading companies, emerging trends, and key segmentations shaping its future.
Projected Market Size and Growth Path for…
Triple Negative Breast Cancer Market Demonstrates Long-Term Growth Potential At …
An in-depth look into the triple negative breast cancer market reveals promising growth and significant advancements in treatment options. As research intensifies and new therapies emerge, this sector is poised for notable expansion and increased innovation in the coming years.
Projected Market Growth of the Triple Negative Breast Cancer Market by 2030
The market for triple negative breast cancer is anticipated to experience substantial growth, reaching a valuation of $1.48…
Treatment-Resistant Depression Market Outlook Signals Expansion To $2.59 Billion …
The treatment-resistant depression market is on track for significant expansion as new therapies and technologies emerge to address persistent challenges in managing this complex condition. With ongoing advancements in personalized medicine and digital health, this sector is expected to evolve rapidly in the coming years. Here's an in-depth look at the market size, key players, influential trends, and detailed segmentation shaping the industry's outlook.
Forecast of the Treatment-Resistant Depression Market Size…
Traumatic Brain Injuries Assessment Market Report 2026 Market Outlook Supported …
The assessment of traumatic brain injuries (TBI) is a rapidly evolving field, driven by technological advancements and a growing need for precise and timely diagnosis. As healthcare providers seek more effective tools to evaluate brain trauma, the market for TBI assessment is poised for notable expansion. Below is an in-depth look at how this market is expected to develop, the leading players involved, and the trends shaping its future.
Traumatic Brain…
More Releases for Diabetes
Diabetes Software Market Revolution: Advancing Intelligent Digital Diabetes Care
The global Diabetes Software Market is witnessing significant transformation as healthcare systems increasingly embrace digital technologies to improve chronic disease management and patient outcomes. The growing need for continuous glucose monitoring, remote patient engagement, and data-driven clinical decision-making has accelerated the adoption of advanced diabetes software solutions across hospitals, clinics, and home care settings. These platforms are helping healthcare providers streamline treatment workflows while enabling patients to actively participate in…
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
